C. D. DiNardo: Research support to institution from AbbVie, Agios, Astex, Beigene, Bristol Myers Squibb, Cleave, Foghorn, Forma/Rigel, ImmuneOnc, Loxo, Servier; consultancy/advisory role with AbbVie, Astellas, Bristol Myers Squibb, Genentech, GenMab, Gilead Sciences, GlaxoSmithKline, Immunogen, Jazz, Novartis, Notable Labs, Rigel, Servier; supported by the LLS Scholar in Clinical Research Award. K. W. Pratz: Research funding from AbbVie, Agios, Daiichi Sankyo, Millennium; advisory board member for AbbVie, Astellas, AstraZeneca, Boston Biomedical, Bristol Myers Squibb, Celgene, Novartis, Roche, Jazz Pharmaceuticals, and Servier. P. Panayiotidis: Grants/research support from AbbVie, Roche, Novartis, and Genesis and honoraria from AbbVie, Janssen, Roche, Novartis, Gilead, and Genesis. X. Wei: No conflicts of interest to disclose. V. Vorobyev: Advisor/consultancy for AbbVie, Janssen, Celgene, Novartis, Pfizer, Takeda, Roche, BeiGene, Amgen, and Sanofi. Á. Illés: Advisor/consultancy for AbbVie, Janssen, Celgene, Novartis, Pfizer, Takeda, Roche. I. Kim: Investigator in AbbVie‐sponsored clinical trials. V. Ivanov: Investigator in AbbVie‐sponsored clinical trials, Novartis, Astellas, MSD, Biocad, and Ascentage Pharma‐sponsored clinical trials; and educational events for AbbVie, Pfizer, Novartis, Roche, Biocad, and Sotex. G. Ku: Employment with Genentech, Inc. and may hold stock or other options. C. L. Miller, M. Zhang, F. Tatsch, J. Potluri, and X. Schmidt: Employment with AbbVie and may hold stock or other options. C. Récher: Consulting or advisory role with AbbVie, Amgen, Astellas, Bristol Myers Squibb, Boehringer, Daiichi‐Sankyo, Jazz Pharmaceuticals, Janssen, and Servier; research funding from AbbVie, Amgen, Astellas, Bristol Myers Squibb, Daiichi‐Sankyo, Iqvia, and Jazz Pharmaceuticals; and support for attending meetings and/or travel from AbbVie, Novartis, and Servier.